422
Views
12
CrossRef citations to date
0
Altmetric
Review

An update on the safety of treating relapsing-remitting multiple sclerosis

, , , , , , & show all
Pages 925-948 | Received 03 Feb 2019, Accepted 19 Aug 2019, Published online: 30 Aug 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Helmut Butzkueven, Jan Hillert, Merja Soilu-Hänninen, Tjalf Ziemssen, Jens Kuhle, Stig Wergeland, Melinda Magyari, Joseph R. Berger, Nicholas Moore, Aida Aydemir, Irene Bezemer & Meritxell Sabidó. (2023) The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis. Current Medical Research and Opinion 0:0, pages 1-16.
Read now
Helmut Butzkueven, Nicholas Moore, Aida Aydemir, Jaak Sõnajalg, Irene Bezemer, Pasi Korhonen & Meritxell Sabidó. (2022) The CLARION study design and status update: a long-term, registry-based study evaluating adverse events of special interest in patients with relapsing multiple sclerosis newly started on cladribine tablets. Current Medical Research and Opinion 38:7, pages 1167-1176.
Read now

Articles from other publishers (10)

Eleonora Sgarlata, Clara Grazia Chisari, Simona Toscano, Chiara Finocchiaro, Salvatore Lo Fermo, Enrico Millefiorini & Francesco Patti. (2022) Changes in John Cunningham Virus Index in Multiple Sclerosis Patients Treated with Different Disease-Modifying Therapies. Current Neuropharmacology 20:10, pages 1978-1987.
Crossref
Tom A. Fuchs, Bethany A. Wattengel, Michael T. Carter, Ali A. El-Solh, Alan J. Lesse & Kari A. Mergenhagen. (2022) Outcomes of multiple sclerosis patients admitted with COVID-19 in a large veteran cohort. Multiple Sclerosis and Related Disorders 64, pages 103964.
Crossref
Francesco Patti, Clara Grazia Chisari, Simona Toscano, Sebastiano Arena, Chiara Finocchiaro, Vincenzo Cimino & Giuseppe Milone. (2022) Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Patients: Monocentric Case Series and Systematic Review of the Literature. Journal of Clinical Medicine 11:4, pages 942.
Crossref
Kaitlin C. Clark, David Wang, Priyadarsini Kumar, Sirjan Mor, Edwin Kulubya, Sabrina V. Lazar & Aijun Wang. (2022) The Molecular Mechanisms Through Which Placental Mesenchymal Stem Cell‐Derived Extracellular Vesicles Promote Myelin Regeneration. Advanced Biology 6:2, pages 2101099.
Crossref
J Hillen, M Ward, M Slee, T Stanford, E Roughead, L Kalisch Ellett & N Pratt. (2022) Utilisation of disease modifying treatment and diversity of treatment pathways in relapsing remitting multiple sclerosis. Multiple Sclerosis and Related Disorders 57, pages 103412.
Crossref
Joseph B. Guarnaccia, Ann Cabot, Lore L. Garten, Salvatore Napoli & Mayer J. Hasbani. (2022) Teriflunomide levels in women whose male sexual partner is on teriflunomide for relapsing multiple sclerosis. Multiple Sclerosis and Related Disorders 57, pages 103347.
Crossref
Simona Toscano, Clara G. Chisari & Francesco Patti. (2021) Multiple Sclerosis, COVID-19 and Vaccines: Making the Point. Neurology and Therapy 10:2, pages 627-649.
Crossref
Georges Jalkh, Rachelle Abi Nahed, Gabrielle Macaron & Mary Rensel. (2020) Safety of Newer Disease Modifying Therapies in Multiple Sclerosis. Vaccines 9:1, pages 12.
Crossref
Alonso Ricardo, Edgar Carnero Contentti, Silva Berenice Anabel, López Pablo Adrian, Garcea Orlando, Hamuy Fernando, Rivera Víctor, Gracia Fernando & Rojas Juan Ignacio. (2020) Decision-making on management of ms and nmosd patients during the COVID-19 pandemic: A latin american survey. Multiple Sclerosis and Related Disorders 44, pages 102310.
Crossref
Xiang Lin & Liwei Lu. 2020. B Cells in Immunity and Tolerance. B Cells in Immunity and Tolerance 145 160 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.